Menopausal Hot Flashes - Pipeline Review, H2 2015

Date: November 25, 2015
Pages: 58
Price:
US$ 2,000.00 US$ 1,700.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: MF9395218AFEN
Leaflet:

Download PDF Leaflet

Menopausal Hot Flashes - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Menopausal Hot Flashes - Pipeline Review, H2 2015’, provides an overview of the Menopausal Hot Flashes’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Menopausal Hot Flashes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global therapeutic landscape of Menopausal Hot Flashes
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Menopausal Hot Flashes and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Menopausal Hot Flashes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Menopausal Hot Flashes pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Menopausal Hot Flashes
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Menopausal Hot Flashes pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Introduction
Global Markets Direct Report Coverage
Menopausal Hot Flashes Overview
Therapeutics Development
Pipeline Products for Menopausal Hot Flashes - Overview
Pipeline Products for Menopausal Hot Flashes - Comparative Analysis
Menopausal Hot Flashes - Therapeutics under Development by Companies
Menopausal Hot Flashes - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Menopausal Hot Flashes - Products under Development by Companies
Menopausal Hot Flashes - Companies Involved in Therapeutics Development
Amgen Inc.
EndoCeutics, Inc.
Pantarhei Bioscience BV
Pherin Pharmaceuticals, Inc.
Pivot Pharmaceuticals Inc
Radius Health, Inc.
Menopausal Hot Flashes - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(prasterone + acolbifene hydrochloride) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AMG-334 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
estetrol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
FP-101 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HBN-2 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
homatropine methylbromide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MNGX-100 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
P-002 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Q-122 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RAD-1901 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Salubrin-HF - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Menopausal Hot Flashes - Recent Pipeline Updates
Menopausal Hot Flashes - Dormant Projects
Menopausal Hot Flashes - Discontinued Products
Menopausal Hot Flashes - Product Development Milestones
Featured News & Press Releases
Sep 26, 2012: Eaton Scientific Highlights International Potential For Tropine 3 As Globally Accepted Non-Hormonal Treatment For Hot Flash Symptoms
Sep 25, 2012: Eaton Scientific Provides Outline On Market Potential Of Tropine 3 For Non-Hormonal Treatment Of Hot Flashes
Sep 13, 2012: Eaton Scientific Teams Up With Urologist Dr Jennifer Berman To Advance Tropine 3 Trials And Marketing
Sep 06, 2012: Eaton Scientific Completes Study Protocol For Phase I/II Study Of Tropine 3 For Treatment Of Hot Flashes
Sep 04, 2012: Eaton Scientific Enters Agreement With RoxSan Pharmacy To Provide Tropine 3 For Upcoming Clinical Trial Participants
Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women
Jun 19, 2010: Radius Presents Positive Phase IIa Study Results Of RAD1901 In Reducing Menopausal Hot Flashes
Jun 08, 2008: Radius Presents Preclinical Study Of RAD1901 At The Endocrine Society 2007 Annual Meeting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Number of Products under Development for Menopausal Hot Flashes, H2 2015
Number of Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Menopausal Hot Flashes - Pipeline by Amgen Inc., H2 2015
Menopausal Hot Flashes - Pipeline by EndoCeutics, Inc., H2 2015
Menopausal Hot Flashes - Pipeline by Pantarhei Bioscience BV, H2 2015
Menopausal Hot Flashes - Pipeline by Pherin Pharmaceuticals, Inc., H2 2015
Menopausal Hot Flashes - Pipeline by Pivot Pharmaceuticals Inc, H2 2015
Menopausal Hot Flashes - Pipeline by Radius Health, Inc., H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Menopausal Hot Flashes Therapeutics - Recent Pipeline Updates, H2 2015
Menopausal Hot Flashes - Dormant Projects, H2 2015
Menopausal Hot Flashes - Dormant Projects (Contd..1), H2 2015
Menopausal Hot Flashes - Discontinued Products, H2 2015

LIST OF FIGURES

Number of Products under Development for Menopausal Hot Flashes, H2 2015
Number of Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Targets, H2 2015
Number of Products by Stage and Targets, H2 2015
Number of Products by Mechanism of Actions, H2 2015
Number of Products by Stage and Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Molecule Types, H2 2015
Number of Products by Stage and Molecule Types, H2 2015
Skip to top


Ask Your Question

Menopausal Hot Flashes - Pipeline Review, H2 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: